Blogs about: Nexmed
Featured Blog
The PM prostate cancer news: Wednesday, July 23
In additional news breaking today: Dendreon Corp. is predicting interim results of the IMPACT study of Provenge in metastatic, androgen-independent prostate cancer by October 2008 The FDA has refused… more →
THE "NEW" PROSTATE CANCER INFOLINK
NexMed receive non approvable letter for topical alprostadil
crimsoncanary wrote 11 months ago: NexMed have received a non approvable letter from … more →
The PM prostate cancer news: Wednesday, July 23
Sitemaster wrote 11 months ago: In additional news breaking today: Dendreon Corp. is predicting interim results of the IMPACT study … more →
Have your say. Start a blog.
See our free features →
An 
Ruckus
